Table 3 The results of pooled rates of studied items (Supplementary Material: Additional file 1: "Availability of Data and Materials")
Studied items | No. of studies | Pooled rates(95 % CI) | Heterogeneity (I 2,%) | Publication bias(P value) |
|---|---|---|---|---|
Awareness | 43 | 15.95 (12.87–19.29) | 98.9 | >0.05 |
Knowledge | 21 | 17.55 (12.38–24.88) | 99.8 | >0.05 |
Acceptability | 35 | 67.25 (58.75–75.21) | 99.8 | >0.05 |
Reasons for unwillingness to be HPV vaccinated | Â | Â | Â | Â |
 Assumed low risk | 14 | 33.63 (27.50–40.05) | 97.2 | >0.05 |
 Limited use to date | 14 | 36.31 (29.67–43.22) | 97.7 | >0.05 |
 Safety | 10 | 50.46 (40.00–60.89) | 96.6 | >0.05 |
 Efficacy | 14 | 30.18 (23.96–36.79) | 97.3 | >0.05 |
 Vaccine source | 11 | 32.17 (21.14–43.30) | 99.2 | >0.05 |
 High price | 6 | 23.72 (13.64–35.59) | 98.2 | >0.05 |
Acceptability (for daughters) | 12 | 60.32 (51.25–69.04) | 99.2 | >0.05 |
Reasons for unwillingness of parents to vaccinate their daughters | Â | Â | Â | Â |
 Limited use to date | 4 | 32.61 (22.03–44.18) | 94.5 | >0.05 |
 Safety and efficacy | 7 | 68.19 (53.13–81.52) | 98.6 | >0.05 |
 Vaccine source | 7 | 17.24 (13.87–20.90) | 82.8 | >0.05 |
 Too young to vaccinate | 7 | 28.37 (13.69–45.90) | 99 | >0.05 |